4 For patients with an entry A1C of 7.5% or higher, the algorithm recommends dual therapy consisting of metformin plus an additional antihyperglycemic agent
These conditions significantly increase the chance of developing cardiovascular disease, stroke, and Type 2 diabetes
This is a key reason why GLP-1 medications are effective for weight management and are a valuable resource in our treatment programs at JosephCareRX
But today, their presence is hard to miss from subway ads to high-profile endorsements by celebrities like Serena Williams, all highlighting the appeal of these once-niche treatments
While there are several reasons you may not be seeing your desired results from a GLP-1, new research points to a cause that might not be on your radar yet: your genes
In addition, the SUMMIT trial evaluates the effect of tirzepatide (the GLP-1/GIP dual receptor agonist) in people with obesity-related HFpEF (Clinicaltrials.gov ID NCT04847557)
